EX-2 3 hu56763862-ex2.htm SCHEDULE OF TRANSACTIONS EFFECTED DURING THE LAST 60 DAYS


EXHIBIT 2
Schedule of Transactions in Shares
The following table sets forth all transactions with respect to Shares effected in the last sixty days by the Reporting Persons or on behalf of the Reporting Persons in respect of the Shares, inclusive of any transactions effected through 4:00 pm, New York City time, on October 18, 2021.
Akoya Biosciences, Inc.

Trade Date
 
Transaction
 
Security
 
Quantity Bought (Sold)
 
Unit Cost(1)
8/19/2021
 
Buy
 
Common Stock
 
6,183
 
$14.68(2)
8/20/2021
 
Buy
 
Common Stock
 
300
 
$14.76(3)
9/1/2021
 
Buy
 
Common Stock
 
1,336
 
$15.25(4)
9/7/2021
 
Buy
 
Common Stock
 
5,000
 
$15.00
9/8/2021
 
Buy
 
Common Stock
 
5,000
 
$14.50
9/23/2021
 
Buy
 
Common Stock
 
15,000
 
$16.74(5)
9/24/2021
 
Buy
 
Common Stock
 
10,000
 
$16.02(6)
10/6/2021
 
Buy
 
Common Stock
 
133,000
 
$12.56(7)
10/8/2021
 
Buy
 
Common Stock
 
5,000
 
$12.74(8)
10/11/2021
 
Buy
 
Common Stock
 
36,800
 
$12.76(9)
10/15/2021
 
Buy
 
Common Stock
 
36,500
 
$12.66(10)
10/18/2021
 
Buy
 
Common Stock
 
19,400
 
$12.79(11)
                 

(1)
Excludes brokerage commissions and other costs of execution.
(2)
The price reported is a weighted average price. These shares were bought in transactions through a broker-dealer at prices ranging from $14.60 to $14.75, inclusive. Hudson Executive and the other Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 2.
(3)
The price reported is a weighted average price. These shares were bought in transactions through a broker-dealer at prices ranging from $14.73 to $14.80, inclusive. Hudson Executive and the other Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 3.
(4)
The price reported is a weighted average price. These shares were bought in transactions through a broker-dealer at prices ranging from $15.22 to $15.25, inclusive. Hudson Executive and the other Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 4.
(5)
The price reported is a weighted average price. These shares were bought in transactions through a broker-dealer at prices ranging from $16.67 to $16.87, inclusive. Hudson Executive and the other Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 5.
(6)
The price reported is a weighted average price. These shares were bought in transactions through a broker-dealer at prices ranging from $15.80 to $16.55, inclusive. Hudson Executive and the other Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 6.



(7)
The price reported is a weighted average price. These shares were bought in transactions through a broker-dealer at prices ranging from $12.40 to $12.64, inclusive. Hudson Executive and the other Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 7.
(8)
The price reported is a weighted average price. These shares were bought in transactions through a broker-dealer at prices ranging from $12.73 to $12.80, inclusive. Hudson Executive and the other Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 8.
(9)
The price reported is a weighted average price. These shares were bought in transactions through a broker-dealer at prices ranging from $12.70 to $12.77, inclusive. Hudson Executive and the other Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 9.
(10)
The price reported is a weighted average price. These shares were bought in transactions through a broker-dealer at prices ranging from $12.44 to $12.80, inclusive. Hudson Executive and the other Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 10.
(11)
The price reported is a weighted average price. These shares were bought in transactions through a broker-dealer at prices ranging from $12.66 to $12.95, inclusive. Hudson Executive and the other Reporting Persons undertake to provide the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 11.